Bio-Rad Laboratories Inc (BIO)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 54.09% | 54.25% | 54.72% | 55.70% | 56.49% | 56.54% | 57.21% | 56.66% | 56.04% | 56.99% | 56.64% | 56.31% | 56.60% | 55.08% | 54.52% | 54.61% | 54.84% | 55.11% | 54.63% | 54.27% |
| Operating profit margin | 12.81% | 13.44% | 13.36% | 14.52% | 17.39% | 17.35% | 19.04% | 18.86% | 17.12% | 19.06% | 18.11% | 16.58% | 16.59% | 12.42% | 10.61% | 10.70% | 10.02% | -2.48% | -3.43% | -3.98% |
| Pretax margin | -32.23% | -6.97% | -19.46% | -9.17% | -169.55% | -281.93% | -90.97% | -7.56% | 186.44% | 287.41% | 181.66% | 196.63% | 193.29% | 190.68% | 109.62% | 87.92% | 98.64% | 22.78% | 53.17% | 34.17% |
| Net profit margin | -24.16% | -5.93% | -15.68% | -6.97% | -130.74% | -217.04% | -67.74% | -3.22% | 145.56% | 223.70% | 140.84% | 151.81% | 149.84% | 148.24% | 85.07% | 68.32% | 76.72% | 16.49% | 39.90% | 25.27% |
Bio-Rad Laboratories Inc. has exhibited a declining trend in its profitability ratios over the past eight quarters. The gross profit margin has gradually decreased from 55.93% in Q4 2022 to 53.42% in Q4 2023, indicating a reduction in the percentage of revenue retained after accounting for the cost of goods sold.
Similarly, the operating profit margin has also experienced a downward trajectory, declining from 17.22% in Q4 2022 to 12.65% in Q4 2023. This suggests a decrease in the company's ability to generate profits from its core operations.
The pretax margin and net profit margin have shown significant volatility, with both ratios demonstrating negative values in multiple quarters. The pretax margin, in particular, plummeted from -167.87% in Q4 2022 to -31.82% in Q4 2023, indicating ongoing challenges in generating profits before accounting for taxes.
Overall, the declining trend in profitability ratios for Bio-Rad Laboratories Inc. raises concerns about the company's operational efficiency and financial health. Investors and stakeholders may need to closely monitor the company's performance and assess the factors contributing to the deteriorating profitability levels.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 2.75% | 3.04% | 3.05% | 2.91% | 3.57% | 4.00% | 4.29% | 3.80% | 2.81% | 2.85% | 3.45% | 3.21% | 3.25% | 2.45% | 2.40% | 2.85% | 2.87% | -0.79% | -1.02% | -1.32% |
| Return on assets (ROA) | -5.18% | -1.34% | -3.58% | -1.40% | -26.87% | -49.99% | -15.26% | -0.65% | 23.90% | 33.41% | 26.80% | 29.43% | 29.34% | 29.29% | 19.28% | 18.19% | 21.96% | 5.25% | 11.83% | 8.36% |
| Return on total capital | -8.06% | -1.44% | -5.01% | -1.87% | -43.15% | -80.65% | -25.47% | -1.87% | 39.80% | 55.86% | 45.12% | 50.17% | 49.81% | 51.51% | 34.37% | 32.60% | 39.59% | 9.77% | 20.76% | 15.10% |
| Return on equity (ROE) | -7.29% | -1.89% | -5.07% | -1.96% | -37.73% | -71.10% | -21.63% | -0.91% | 31.09% | 43.47% | 34.94% | 38.65% | 38.49% | 39.89% | 26.48% | 25.10% | 30.55% | 7.34% | 16.49% | 11.80% |
Bio-Rad Laboratories Inc.'s profitability ratios show varying trends over the past eight quarters.
- Operating return on assets (Operating ROA) decreased from 3.57% in Q4 2022 to 2.75% in Q4 2023, indicating a decline in the company's ability to generate operating income from its assets.
- Return on assets (ROA) also saw a decline, ranging from -26.87% in Q4 2022 to -5.18% in Q4 2023. This negative trend suggests that the company's net income generated from its total assets has been consistently low or negative.
- The return on total capital remained relatively stable, hovering around the range of 3.40% to 4.80% over the quarters. This ratio indicates the company's ability to generate profits from its total capital employed.
- Return on equity (ROE) fluctuated significantly, reaching a low of -71.39% in Q3 2022 and improving to -7.29% in Q4 2023. The negative ROE values suggest that the company has not been able to generate positive returns for its shareholders during these periods.
Overall, the company's profitability ratios paint a mixed picture, with varying levels of performance across different quarters. Further investigation into the factors driving these trends would be necessary to understand the underlying reasons for the fluctuations in profitability.